NCT07412548Not yet recruiting
Autogenic Relaxation and Murottal Therapy in Hemodialysis Patients
The Effectiveness of Autogenic Relaxation and Surah Ar-Rahman Murottal Therapy on Anxiety, Sleep Quality, and Hemodynamic Parameters in Hemodialysis Patients
Source: ClinicalTrials.gov · Last updated 17 Feb 2026
Brief summary (registry, in English)
This quasi-experimental study aims to evaluate the effect of combined autogenic relaxation and Surah Ar-Rahman murottal therapy on anxiety, sleep quality, and hemodynamic parameters in hemodialysis patients. A pretest-posttest control group design will be used involving 76 participants undergoing routine hemodialysis. Participants will be assigned to an intervention group receiving structured autogenic relaxation followed by murottal therapy and a control group receiving standard care with music listening. Anxiety, sleep quality, and hemodynamic parameters will be measured at baseline and after a 6-week intervention period. The findings are expected to support the use of non-pharmacological and spiritual-based interventions in improving psychological and physiological outcomes in hemodialysis patients.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 76 (estimated)
- First submitted
- 27 Jan 2026
- Start date
- 1 Mar 2026
- Primary completion date
- 31 May 2026
- Lead sponsor
- Universitas Muhammadiyah Surakarta
- Diseases
- Chronic kidney disease
- NCT number
- NCT07412548
What you commit to
- Study type: Interventional
- Planned participants: 76
- From 1 Mar 2026 to the primary completion date, 31 May 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Having a severe heart condition or an unstable critical condition.
- Having a severe psychiatric disorder (schizophrenia, major depression).
- Having a cognitive, hearing, or speech disorder that impedes communication.
Other
- Taking antidepressants, anxiolytics, or neuroleptics that may affect psychological measurement results.
Who the study is looking for
- Patients diagnosed with stage V chronic kidney disease.
- Undergoing scheduled hemodialysis at least twice a week for 6 weeks.
- Outpatients and aged 18-65 years.
- Muslim.
- Cooperative and able to communicate verbally.
- Willing to be a respondent by signing an informed consent form.
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Indriati Hospital Coordinator of this site? Confirm its status | Sukoharjo | Indonesia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.